Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11945794 Nuclear transport modulators and uses thereof

Patent 11945794 was granted and assigned to Karyopharm Therapeutics on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Karyopharm Therapeutics

0

Current Assignee

Karyopharm Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Yosef Landesman0

Sharon Shacham0

Erkan Baloglu0

William Senapedis0

Trinayan Kashyap0

Sharon Shechter0

Ori Kalid0

Gali Golan0

...

Date of Patent

April 2, 2024

0

Patent Application Number

174091500

Date Filed

August 23, 2021

0

Patent Citations

US Patent 8273738 Imidazole derivatives

0

US Patent 8299102 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals

0

US Patent 8304438 Heteroarylacrylamides and their use as pharmaceuticals

0

US Patent 8513230 Nuclear transport modulators and uses thereof

0

US Patent 8598168 Inhibitors of histone deacetylase

0

US Patent 8999996 Hydrazide containing nuclear transport modulators and uses thereof

0

US Patent 9079865 Hydrazide containing nuclear transport modulators and uses thereof

0

US Patent 7342115 3-substituted-6-aryl pyridines

0

...

Patent Primary Examiner

Brenda L Coleman

0

CPC Code

0

0

0

0

0

0

0

0

...

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11945794 Nuclear transport modulators and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool